On Invalid Date, Lifemd (NASDAQ: LFMD) reported Q1 2023 earnings per share (EPS) of -$0.15, up 67.39% year over year. Total Lifemd earnings for the quarter were -$4.79 million. In the same quarter last year, Lifemd's earnings per share (EPS) was -$0.46.
As of Q2 2023, Lifemd's earnings has grown year over year. Lifemd's earnings in the past year totalled -$39.35 million.
What was LFMD's revenue last quarter?
On Invalid Date, Lifemd (NASDAQ: LFMD) reported Q1 2023 revenue of $33.13 million up 14.06% year over year. In the same quarter last year, Lifemd's revenue was $29.04 million.
What was LFMD's revenue growth in the past year?
As of Q2 2023, Lifemd's revenue has grown 18.7% year over year. This is 20.34 percentage points higher than the US Pharmaceutical Retailers industry revenue growth rate of -1.64%. Lifemd's revenue in the past year totalled $123.12 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.